
Eli Lilly has said it is downsizing its plant in County Cork, Ireland, by around 14% in light of patent …
GlaxoSmithKline’s first-in-class lupus drug Benlysta has been given a major boost by regulators in the European Union. The European Medicines …
Pfizer and Bristol-Myers Squibb’s eagerly anticipated blood thinner Eliquis has gained European approval. A twice-daily oral Factor Xa inhibitor, Eliquis …
Health secretary Andrew Lansley has declared that cancer networks will be maintained, reversing an earlier decision to axe them. Lansley …

MedeConnect Healthcare Insight, the market research division of Doctors.net.uk, has strengthened its senior research team with the appointment of Nicola …
The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is ‘‘inefficient, underutilised …

Pfizer’s football-themed campaign to raise awareness of ankylosing spondylitis has picked up one of a brace of awards for the …

The Red Consultancy has hired Sarah McKinnon Clark as an account manager for its specialist health team Red Health. She …
The use of a promotional magnet by marketers at Shire has attracted trouble from the FDA. The magnet, which is …

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …

Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
The government’s radical reform of the NHS must focus on integrated care and not just GPs, according to the chairman …
A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …

Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
Canadian contract manufacturer Patheon has appointed Michael Lytton as executive VP, corporate development and strategy, and general counsel. He moves …

The rise of digital marketing in the pharma sector has brought renewed focus to tracking effectiveness, because digital is seen …
Grunenthal is negotiating a 360 million euro deal to sell Central and Eastern European rights to some of its pain …

Dick Dunford has joined UK healthcare communications agency TBWA\ Paling Walters as its executive creative director. He has over 20 …

Merck & Co and Roche have signed an agreement that will see them co-promote each other’s hepatitis C drugs in …